FUNDING THE BEST BRAINS TO BEAT BRAIN CANCER
Dr Charlie Teo AM, Professor of Neurosurgery
Director and Founder, Charlie Teo Foundation
FUNDER PROFILE
Filmed in Sydney, Australia | December 2024
The Charlie Teo Foundation is dedicated to funding and advancing research into brain cancer, with a particular focus on developing more effective treatments and finding a cure for this devastating disease. The foundation’s mission includes:
- Supporting cutting-edge research: The foundation funds innovative research into brain cancer, aiming to discover new therapies, improve outcomes, and ultimately find a cure.
- Raising awareness: The foundation works to increase public awareness about brain cancer, its impact on patients and families, and the need for more research and funding in this field.
- Helping patients: In addition to supporting research, the foundation assists individuals and families affected by brain cancer by providing information, resources, and support.
- Advocating for change: It strives to drive systemic change in how brain cancer is researched and treated, challenging the status quo and encouraging collaboration and innovation within the medical community.
Dr. Charlie Teo AM as the Founder and Director of the Charlie Teo Foundation, has for over 30 years been instrumental in the development, dissemination and acceptance of the concept of keyhole minimally invasive techniques in neurosurgery. Dr Teo ran a fellowship program that attracts over 600 applicants yearly and has trained many of the world’s leading figures in neurosurgery. He has trained at distinguished centres such as the Barrow Neurological Institute, Johns Hopkins University, Duke University, Stanford University, Vanderbilt University and Harvard University.
Initially focused on Australia, Dr Teo recognised a pressing need to raise funds for brain cancer research from a young age. To address this, he founded the Charlie Teo Foundation in 2017, which aims to increase awareness and funding for brain cancer research.
Brain cancer significantly impacts society, being the leading cause of years of life lost. Despite its high incidence, particularly among young adults and children, it remains one of the least funded cancers. The foundation operates with low overhead costs and focuses on supporting disruptive researchers who think outside the box.
Since its inception, the foundation has committed nearly $15 million to brain cancer research, funding notable projects in Australia and the United States. These projects explore innovative approaches to understand and treat brain cancer more effectively, with a focus on translating findings from animal studies to human applications. Charlie’s dedication to finding solutions for this devastating disease remains unwavering as he travels frequently to collaborate with global researchers.
-
Digital Biomarkers and AI for Optimal Diagnosis, Treatment, and Decision-Making
Associate Professor Johan Verjans is a clinician-scientist with a strong focus on cross-disciplinary translational research. In his role as Deputy Director at the Australian Institute for Machine Learning (AIML)—one of the world’s premier machine learning institutes, with over 200 researchers—and as Group Leader of Artificial Intelligence at the South Australian Health and Medical Research Institute (SAHMRI), he integrates his expertise in molecular medicine, clinical research, and advanced imaging with machine learning applications. This unique combination enables him to drive the translation of cutting-edge AI research into practical medical applications. He works with global teams from multinationals on AI problems.
-
Professor Maria Makrides
SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE (SAHMRI)
SOUTH AUSTRALIA
AUSTRALIA
NEW SOUTH WALES, AUSTRALIA -
Impact of Leukaemia Foundation’s Research Funding into Blood Cancer
Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.
